about
Luria's three-step test: what is it and what does it tell us?Genetic and clinical features of progranulin-associated frontotemporal lobar degenerationWhite matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors.Benchmarking a test of temporal orientation with data from american and taiwanese persons with Alzheimer's disease and american normal elderly.FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.Cerebral blood volume in Alzheimer's disease and correlation with tissue structural integrity.Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease.Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample.High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.Molecular neuropsychology: creation of test-specific blood biomarker algorithms.Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study.Videoconference diagnosis and management of Choctaw Indian dementia patientsA simple method to rule out dementia with temporal orientation.Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization.Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injuryThe relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians.Regional changes of cortical mean diffusivities with aging after correction of partial volume effects.Annualized functional change in Alzheimer's disease participants and normal controls.Perspective on race and ethnicity in Alzheimer's disease research.Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.Consumer acceptability of brief videoconference-based neuropsychological assessment in older individuals with and without cognitive impairmentLeptin and cognition.Lipids and adipokines as risk factors for Alzheimer's disease.Brain MRI, apoliprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controlsGlobal brain hypoperfusion and oxygenation in amnestic mild cognitive impairment.Executive functioning and the metabolic syndrome: a project FRONTIER study.Treatment of behavioral/psychological symptoms in Alzheimer's disease.Impact of delirium on the course of Alzheimer disease.Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions.Risk factors for potentially harmful informal caregiver behavior.Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center Longitudinal Study.A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease.Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia.Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil.Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease.Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients.
P50
Q30425950-8C89995F-C892-41AD-AC2F-1537A8520ADEQ30503638-32DEA078-BB84-482D-B144-635A3033B034Q30587379-5569A64B-0484-4A10-96F1-6ED2F90DDAE1Q33208045-244507B4-D42D-4CF3-9D59-D937D18E0F91Q33922335-30C6F79B-0A60-4F74-A89A-FB0185B95247Q33925140-22DD743A-DD9B-4B8F-A8CE-0EC8B1FBBB21Q33959584-1244ED77-702D-4E66-8DA0-7216AABADA29Q34019643-8A49A191-9767-4530-9318-D7A8F04AAD73Q34598450-FEB3D86B-1726-4775-AA1B-27D371F961F9Q35456265-E96730B0-846F-43E5-A29E-FE4C90556474Q35460864-A9C1F5CE-CE42-4B0E-9FAE-7777F228EB11Q35534410-3B315032-6750-4FED-9808-E9D4FB026895Q35570896-6DBA5438-3D1E-49A5-B8BF-B9797E67AECDQ35583140-C93D8D4B-82BA-4D85-87F1-234C4077FBFCQ35844926-94E7EAC4-71B4-4FD8-A799-F92606D52478Q36102923-EE57A313-A6DA-44F9-855C-84E09C434AA2Q36156458-68919363-D23A-43CC-A5AA-8BA46C2D5DE0Q36614711-FC7A20CD-3B6C-4E76-B8F6-7703035F5157Q36935202-4F904DFA-3945-428A-BE9D-040A1978BFAEQ36943236-4C69DCDD-DFDB-405D-B1D9-D26536F42B40Q36954186-B482CF3F-6E2E-429F-8983-E1BD1F8A7C50Q36955007-13E66FFE-67FB-4CDF-9C08-6D4B757B9F39Q37066904-EE06A0E6-DE3D-4CE1-9779-513AC069A4BDQ37066912-3806631A-4525-49A0-A3A3-7004250B2342Q37364216-BB255196-FEC8-4B9E-A245-BE7C76C34876Q37384667-4FDBDD07-961A-4FF9-B875-5E9878B326F3Q37498745-5C1DB78B-797C-4D9A-9A81-6E0EA1DADB26Q37610297-AEF315F1-4383-41A2-B539-B88B2CCAC292Q38044201-AA7F52FB-4BE1-438A-88C8-9C5D725780DAQ38419390-22AAA398-6C96-47F9-A644-13E66171B291Q39706244-9114CFFF-86E4-4CBD-962C-E2AB1B38FEADQ39741463-BA79F93A-3633-4C40-BF44-2056CC69EC6BQ44288196-F30A728E-448C-4C58-AF05-6BFD7A8CA50FQ44336296-5FBB55E7-0B29-47E9-B9D1-755705A9C442Q44411234-16148766-3A4E-4CC5-9269-AECB6248AA8DQ45169053-66BD57C7-7FF4-411A-83BB-450253A01E78Q45189697-B15E8AFC-8E54-4900-A7FF-B70D211FB857Q45982207-5A2E125D-F9FD-4DFF-A6C6-373ED205B320Q46068068-550D16CC-14C5-44D9-AEF1-84EB47E76C7EQ46164301-2CC75FA9-34A3-48A8-9A9D-1DEBB8549D5C
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Myron F Weiner
@nl
Myron F Weiner
@sl
Myron F. Weiner
@en
Myron F. Weiner
@es
type
label
Myron F Weiner
@nl
Myron F Weiner
@sl
Myron F. Weiner
@en
Myron F. Weiner
@es
prefLabel
Myron F Weiner
@nl
Myron F Weiner
@sl
Myron F. Weiner
@en
Myron F. Weiner
@es
P1006
P214
P244
P1006
P106
P1153
7402253653
P1580
P21
P214
P244
P31
P496
0000-0001-5682-4410
P569
1934-06-04T00:00:00Z
P7859
lccn-n77014682